Foyston, Gordon, & Payne Inc Merck & Co., Inc. Transaction History

Foyston, Gordon, & Payne Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 02, 2018	SELL	$57.69 - $67.84 $2.1 Million - $2.47 Million	-36,454 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$50.83 - $59.72 $1.81 Million - $2.12 Million	-35,550 Reduced 49.37%	36,454 $2.21 Million
Q1 2018 May 14, 2018	SELL	$50.96 - $59.23 $148,854 - $173,010	-2,921 Reduced 3.9%	72,004 $3.92 Million
Q4 2017 Feb 14, 2018	SELL	$51.62 - $61.64 $180,979 - $216,109	-3,506 Reduced 4.47%	74,925 $4.22 Million
Q3 2017 Nov 14, 2017	SELL	$58.67 - $63.13 $50,925 - $54,796	-868 Reduced 1.09%	78,431 $5.02 Million
Q2 2017 Aug 14, 2017	BUY	N/A	79,299	79,299 $5.08 Million

3,826

1.91B

13.4M

10.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $278B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Foyston, Gordon, & Payne Inc, based on Form 13F filings with the SEC.

Stay updated on Foyston, Gordon, & Payne Inc with notifications on news.